Tickerplace logo

Tickerplace

Galectin Therapeutics Inc. logo

GALTGalectin Therapeutics Inc.

GALT Stock Price, Valuation & Chart | Galectin Therapeutics Inc.

Compare
$4.480+0.31 (+7.43%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyGALT intrinsic valueGALT calculated fair value vs price
OverviewFinancialsDividendsRatios

GALT Historical price chart

GALT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization295.04M
PE Ratio-10.93
EPS-0.41
Trading Volume460.43K
Today's High/Low4.53/4.19
Dividend Yield0.00
52 Week High/Low7.13/2.03
Shares Outstanding65.86M
GALT Financial Statement
GALT Analyst ratings
GALT Analysis & performance metrics

GALT Company profile

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The…

GALT Management team

Management
Beth Knowles
Executive Assistant & Officer Manager
Jeff Katstra
Head of CMC & Pharmaceutical Development
Joel Lewis CPACEO
President, Chief Executive Officer & Director
Jack W. Callicutt CPACFO
Chief Financial Officer, Treasurer & Corporate Secretary
Khurram Jamil M.D.
Chief Medical Officer
Robert Tritt J.D.
General Counsel
Total 6 executives

GALT Frequently asked questions

What is Galectin Therapeutics Inc. (GALT) Stock Price?

Current stock price of Galectin Therapeutics Inc. (GALT) stock is $4.480. The stock price is +7.43% higher in the session. The intraday range can be seen from this page. Volume of Galectin Therapeutics Inc. (GALT) stock is 460.43K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Galectin Therapeutics Inc. (GALT) stock price going up or down today?

The stock price of Galectin Therapeutics Inc. (GALT) can change with earnings, company news, and overall market sentiment. Galectin Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Galectin Therapeutics Inc. stock expensive at its current price?

Whether Galectin Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GALT on this page is -10.93. EPS on this page is -0.41. Compare those figures with peers and growth expectations before deciding if the current Galectin Therapeutics Inc. price is justified.

How has the stock price of Galectin Therapeutics Inc. (GALT) performed historically?

Historical performance for Galectin Therapeutics Inc. (GALT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GALT reacted to past earnings and market events.

Should I buy Galectin Therapeutics Inc. (GALT) stock, at this price?

Buying Galectin Therapeutics Inc. (GALT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.